nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—NEU1—bronchus—chronic obstructive pulmonary disease	0.0176	0.194	CbGeAlD
Oseltamivir—NEU1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0172	0.19	CbGeAlD
Oseltamivir—NEU1—trachea—chronic obstructive pulmonary disease	0.0158	0.174	CbGeAlD
Oseltamivir—NEU1—lung—chronic obstructive pulmonary disease	0.0114	0.125	CbGeAlD
Oseltamivir—CES1—respiratory system—chronic obstructive pulmonary disease	0.00861	0.095	CbGeAlD
Oseltamivir—CES1—connective tissue—chronic obstructive pulmonary disease	0.00758	0.0836	CbGeAlD
Oseltamivir—NEU1—Post-translational protein modification—MUC5AC—chronic obstructive pulmonary disease	0.00506	0.0463	CbGpPWpGaD
Oseltamivir—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00477	0.0526	CbGeAlD
Oseltamivir—CES1—lung—chronic obstructive pulmonary disease	0.00457	0.0504	CbGeAlD
Oseltamivir—NEU1—Post-translational protein modification—MUC1—chronic obstructive pulmonary disease	0.0043	0.0394	CbGpPWpGaD
Oseltamivir—NEU2—Post-translational protein modification—MUC5AC—chronic obstructive pulmonary disease	0.00384	0.0351	CbGpPWpGaD
Oseltamivir—NEU2—Post-translational protein modification—MUC1—chronic obstructive pulmonary disease	0.00326	0.0298	CbGpPWpGaD
Oseltamivir—ABCC4—lung—chronic obstructive pulmonary disease	0.00308	0.0339	CbGeAlD
Oseltamivir—CES1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.0026	0.0238	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.0024	0.022	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00236	0.0216	CbGpPWpGaD
Oseltamivir—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00217	0.00271	CcSEcCtD
Oseltamivir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00271	CcSEcCtD
Oseltamivir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00217	0.00271	CcSEcCtD
Oseltamivir—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00269	CcSEcCtD
Oseltamivir—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00269	CcSEcCtD
Oseltamivir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.00268	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00213	0.00267	CcSEcCtD
Oseltamivir—Delirium—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00266	CcSEcCtD
Oseltamivir—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00266	CcSEcCtD
Oseltamivir—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00264	CcSEcCtD
Oseltamivir—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00264	CcSEcCtD
Oseltamivir—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00264	CcSEcCtD
Oseltamivir—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00264	CcSEcCtD
Oseltamivir—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00211	0.00263	CcSEcCtD
Oseltamivir—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00209	0.00261	CcSEcCtD
Oseltamivir—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00209	0.00261	CcSEcCtD
Oseltamivir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.0026	CcSEcCtD
Oseltamivir—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00259	CcSEcCtD
Oseltamivir—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00258	CcSEcCtD
Oseltamivir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00206	0.00258	CcSEcCtD
Oseltamivir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00206	0.00258	CcSEcCtD
Oseltamivir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00205	0.00256	CcSEcCtD
Oseltamivir—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00256	CcSEcCtD
Oseltamivir—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00256	CcSEcCtD
Oseltamivir—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00256	CcSEcCtD
Oseltamivir—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00256	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00204	0.0187	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00252	CcSEcCtD
Oseltamivir—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00251	CcSEcCtD
Oseltamivir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.002	0.0025	CcSEcCtD
Oseltamivir—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00249	CcSEcCtD
Oseltamivir—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00199	0.00249	CcSEcCtD
Oseltamivir—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00249	CcSEcCtD
Oseltamivir—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00247	CcSEcCtD
Oseltamivir—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00247	CcSEcCtD
Oseltamivir—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.00246	CcSEcCtD
Oseltamivir—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00197	0.00246	CcSEcCtD
Oseltamivir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00195	0.00243	CcSEcCtD
Oseltamivir—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00242	CcSEcCtD
Oseltamivir—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00193	0.00242	CcSEcCtD
Oseltamivir—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00192	0.0024	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00237	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00235	CcSEcCtD
Oseltamivir—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00234	CcSEcCtD
Oseltamivir—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00234	CcSEcCtD
Oseltamivir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00186	0.00233	CcSEcCtD
Oseltamivir—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00233	CcSEcCtD
Oseltamivir—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00233	CcSEcCtD
Oseltamivir—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00233	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00185	0.0169	CbGpPWpGaD
Oseltamivir—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00183	0.00229	CcSEcCtD
Oseltamivir—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00228	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00182	0.0166	CbGpPWpGaD
Oseltamivir—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00227	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00179	0.0164	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00223	CcSEcCtD
Oseltamivir—NEU1—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.00178	0.0163	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00222	CcSEcCtD
Oseltamivir—Cough—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00222	CcSEcCtD
Oseltamivir—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00222	CcSEcCtD
Oseltamivir—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00221	CcSEcCtD
Oseltamivir—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.0022	CcSEcCtD
Oseltamivir—Cough—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00218	CcSEcCtD
Oseltamivir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00217	CcSEcCtD
Oseltamivir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00217	CcSEcCtD
Oseltamivir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00217	CcSEcCtD
Oseltamivir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00217	CcSEcCtD
Oseltamivir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00217	CcSEcCtD
Oseltamivir—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00216	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00215	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00215	CcSEcCtD
Oseltamivir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00212	CcSEcCtD
Oseltamivir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00212	CcSEcCtD
Oseltamivir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00212	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00169	0.0155	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00211	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00211	CcSEcCtD
Oseltamivir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.0021	CcSEcCtD
Oseltamivir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00208	CcSEcCtD
Oseltamivir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00208	CcSEcCtD
Oseltamivir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00206	CcSEcCtD
Oseltamivir—Infection—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00206	CcSEcCtD
Oseltamivir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00205	CcSEcCtD
Oseltamivir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00205	CcSEcCtD
Oseltamivir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00205	CcSEcCtD
Oseltamivir—NEU1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00163	0.0149	CbGpPWpGaD
Oseltamivir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00204	CcSEcCtD
Oseltamivir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00204	CcSEcCtD
Oseltamivir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00204	CcSEcCtD
Oseltamivir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00204	CcSEcCtD
Oseltamivir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00204	CcSEcCtD
Oseltamivir—Infection—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00202	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00162	0.0148	CbGpPWpGaD
Oseltamivir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00202	CcSEcCtD
Oseltamivir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00202	CcSEcCtD
Oseltamivir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00201	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.0016	0.0147	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0016	0.002	CcSEcCtD
Oseltamivir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00199	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.00158	0.0145	CbGpPWpGaD
Oseltamivir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00198	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00157	0.0144	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00196	CcSEcCtD
Oseltamivir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00195	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00155	0.0142	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00154	0.0141	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00192	CcSEcCtD
Oseltamivir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00191	CcSEcCtD
Oseltamivir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00191	CcSEcCtD
Oseltamivir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.0019	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00189	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00189	CcSEcCtD
Oseltamivir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00188	CcSEcCtD
Oseltamivir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00188	CcSEcCtD
Oseltamivir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00187	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00185	CcSEcCtD
Oseltamivir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00184	CcSEcCtD
Oseltamivir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00183	CcSEcCtD
Oseltamivir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00183	CcSEcCtD
Oseltamivir—Injury—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00181	CcSEcCtD
Oseltamivir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00181	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00179	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00179	CcSEcCtD
Oseltamivir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00179	CcSEcCtD
Oseltamivir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00179	CcSEcCtD
Oseltamivir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00179	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00179	CcSEcCtD
Oseltamivir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00178	CcSEcCtD
Oseltamivir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00178	CcSEcCtD
Oseltamivir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00177	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00176	CcSEcCtD
Oseltamivir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00175	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.0014	0.0128	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.0014	0.0128	CbGpPWpGaD
Oseltamivir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00174	CcSEcCtD
Oseltamivir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00174	CcSEcCtD
Oseltamivir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00173	CcSEcCtD
Oseltamivir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00172	CcSEcCtD
Oseltamivir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00172	CcSEcCtD
Oseltamivir—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00171	CcSEcCtD
Oseltamivir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00171	CcSEcCtD
Oseltamivir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00171	CcSEcCtD
Oseltamivir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00171	CcSEcCtD
Oseltamivir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.0017	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00136	0.0017	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.0017	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00169	CcSEcCtD
Oseltamivir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00169	CcSEcCtD
Oseltamivir—NEU2—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.00135	0.0124	CbGpPWpGaD
Oseltamivir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00168	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00134	0.0122	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00166	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00166	CcSEcCtD
Oseltamivir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00165	CcSEcCtD
Oseltamivir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00165	CcSEcCtD
Oseltamivir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00164	CcSEcCtD
Oseltamivir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00164	CcSEcCtD
Oseltamivir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00164	CcSEcCtD
Oseltamivir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00164	CcSEcCtD
Oseltamivir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00164	CcSEcCtD
Oseltamivir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00162	CcSEcCtD
Oseltamivir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00162	CcSEcCtD
Oseltamivir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00162	CcSEcCtD
Oseltamivir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00162	CcSEcCtD
Oseltamivir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00162	CcSEcCtD
Oseltamivir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00161	CcSEcCtD
Oseltamivir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00161	CcSEcCtD
Oseltamivir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00161	CcSEcCtD
Oseltamivir—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00161	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.0016	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00125	0.0114	CbGpPWpGaD
Oseltamivir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00156	CcSEcCtD
Oseltamivir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00155	CcSEcCtD
Oseltamivir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00155	CcSEcCtD
Oseltamivir—NEU2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00124	0.0113	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00123	0.0112	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00153	CcSEcCtD
Oseltamivir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00153	CcSEcCtD
Oseltamivir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00153	CcSEcCtD
Oseltamivir—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00153	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00121	0.0111	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.0012	0.011	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0012	0.0015	CcSEcCtD
Oseltamivir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00149	CcSEcCtD
Oseltamivir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00149	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00119	0.0109	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00117	0.0107	CbGpPWpGaD
Oseltamivir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00146	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00116	0.0107	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00145	CcSEcCtD
Oseltamivir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00142	CcSEcCtD
Oseltamivir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00142	CcSEcCtD
Oseltamivir—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00141	CcSEcCtD
Oseltamivir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00141	CcSEcCtD
Oseltamivir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00139	CcSEcCtD
Oseltamivir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00137	CcSEcCtD
Oseltamivir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00137	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00109	0.00998	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00108	0.0099	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00108	0.00987	CbGpPWpGaD
Oseltamivir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00135	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00108	0.00984	CbGpPWpGaD
Oseltamivir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00134	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.00982	CbGpPWpGaD
Oseltamivir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00132	CcSEcCtD
Oseltamivir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00132	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GC—chronic obstructive pulmonary disease	0.00105	0.00963	CbGpPWpGaD
Oseltamivir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00131	CcSEcCtD
Oseltamivir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00131	CcSEcCtD
Oseltamivir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00131	CcSEcCtD
Oseltamivir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00131	CcSEcCtD
Oseltamivir—Headache—Formoterol—chronic obstructive pulmonary disease	0.00104	0.0013	CcSEcCtD
Oseltamivir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.0013	CcSEcCtD
Oseltamivir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.0013	CcSEcCtD
Oseltamivir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00129	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00103	0.00944	CbGpPWpGaD
Oseltamivir—Rash—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00128	CcSEcCtD
Oseltamivir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00128	CcSEcCtD
Oseltamivir—Headache—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00127	CcSEcCtD
Oseltamivir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00126	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000999	0.00914	CbGpPWpGaD
Oseltamivir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000998	0.00125	CcSEcCtD
Oseltamivir—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000991	0.00124	CcSEcCtD
Oseltamivir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00124	CcSEcCtD
Oseltamivir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00124	CcSEcCtD
Oseltamivir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00123	CcSEcCtD
Oseltamivir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00123	CcSEcCtD
Oseltamivir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00123	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000978	0.00895	CbGpPWpGaD
Oseltamivir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000967	0.00121	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000959	0.00877	CbGpPWpGaD
Oseltamivir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000956	0.00119	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000941	0.00861	CbGpPWpGaD
Oseltamivir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00117	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00092	0.00841	CbGpPWpGaD
Oseltamivir—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000916	0.00115	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000914	0.00836	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.0009	0.00113	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000883	0.00807	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000866	0.00793	CbGpPWpGaD
Oseltamivir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00086	0.00108	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00085	0.00777	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000845	0.00773	CbGpPWpGaD
Oseltamivir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000832	0.00104	CcSEcCtD
Oseltamivir—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000823	0.00103	CcSEcCtD
Oseltamivir—NEU2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00082	0.0075	CbGpPWpGaD
Oseltamivir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000814	0.00102	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000813	0.00744	CbGpPWpGaD
Oseltamivir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000807	0.00101	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GC—chronic obstructive pulmonary disease	0.000798	0.0073	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00078	0.00713	CbGpPWpGaD
Oseltamivir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00077	0.000962	CcSEcCtD
Oseltamivir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.000927	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000741	0.00678	CbGpPWpGaD
Oseltamivir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000741	0.000926	CcSEcCtD
Oseltamivir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000737	0.000921	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000736	0.00674	CbGpPWpGaD
Oseltamivir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000732	0.000915	CcSEcCtD
Oseltamivir—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00072	0.0009	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000717	0.00656	CbGpPWpGaD
Oseltamivir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000715	0.000894	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000713	0.00653	CbGpPWpGaD
Oseltamivir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000694	0.000868	CcSEcCtD
Oseltamivir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000682	0.000853	CcSEcCtD
Oseltamivir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000682	0.000853	CcSEcCtD
Oseltamivir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00068	0.00085	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000678	0.000847	CcSEcCtD
Oseltamivir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000663	0.000829	CcSEcCtD
Oseltamivir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000654	0.000818	CcSEcCtD
Oseltamivir—Infection—Prednisone—chronic obstructive pulmonary disease	0.00065	0.000812	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000649	0.00594	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000644	0.00589	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000641	0.000802	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000641	0.00586	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000641	0.00586	CbGpPWpGaD
Oseltamivir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000635	0.000794	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000632	0.00578	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000622	0.00569	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000615	0.00563	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000614	0.00562	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000604	0.00553	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000596	0.000745	CcSEcCtD
Oseltamivir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000595	0.000744	CcSEcCtD
Oseltamivir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00074	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000591	0.0054	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000589	0.00539	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000586	0.00536	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000585	0.00535	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000585	0.00535	CbGpPWpGaD
Oseltamivir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000576	0.00072	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000575	0.00526	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000568	0.0052	CbGpPWpGaD
Oseltamivir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.000709	CcSEcCtD
Oseltamivir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000567	0.000709	CcSEcCtD
Oseltamivir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000564	0.000705	CcSEcCtD
Oseltamivir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000564	0.000705	CcSEcCtD
Oseltamivir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000539	0.000674	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000669	CcSEcCtD
Oseltamivir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.000668	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00053	0.00485	CbGpPWpGaD
Oseltamivir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00065	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000519	0.00474	CbGpPWpGaD
Oseltamivir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000646	CcSEcCtD
Oseltamivir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000646	CcSEcCtD
Oseltamivir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000602	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000478	0.00437	CbGpPWpGaD
Oseltamivir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000469	0.000587	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000458	0.00419	CbGpPWpGaD
Oseltamivir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000448	0.000559	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000444	0.00407	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000443	0.00405	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000436	0.00399	CbGpPWpGaD
Oseltamivir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000433	0.000541	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000431	0.00394	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000423	0.00387	CbGpPWpGaD
Oseltamivir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000416	0.00052	CcSEcCtD
Oseltamivir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000412	0.000516	CcSEcCtD
Oseltamivir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000412	0.000515	CcSEcCtD
Oseltamivir—Headache—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000512	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000403	0.00369	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000402	0.00367	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000399	0.00365	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000393	0.0036	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000393	0.0036	CbGpPWpGaD
Oseltamivir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000486	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000388	0.00355	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000388	0.00355	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.00037	0.00338	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00037	0.00338	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000366	0.00335	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00331	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000347	0.00318	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00032	0.00293	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000302	0.00276	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000298	0.00272	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000294	0.00269	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000287	0.00263	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00028	0.00257	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000278	0.00254	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000273	0.0025	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000272	0.00249	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00241	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000259	0.00237	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000249	0.00228	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.00024	0.0022	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000237	0.00217	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000236	0.00216	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000226	0.00207	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000211	0.00193	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000202	0.00185	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000188	0.00172	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000185	0.00169	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000182	0.00166	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000179	0.00164	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000172	0.00158	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000171	0.00157	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000167	0.00153	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000143	0.0013	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000141	0.00129	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	0.00014	0.00128	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000134	0.00123	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000127	0.00116	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000122	0.00111	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.67e-05	0.000885	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.88e-05	0.000812	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	7.31e-05	0.000669	CbGpPWpGaD
